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Why a protein-interactions ontology?
The prediction and analysis of a protein’s func-
tion is an ongoing challenge in the ﬁeld of
genomics. With upcoming datasets on protein inter-
actions [9], it is becoming evident that the function
of a protein can only be understood when taking
its interaction with other molecules into account.
Most current approaches to the classiﬁcation and
description of protein function, such as the Gene
Ontology [8], focus on single proteins. These anno-
tation efforts should be paralleled by the develop-
ment of ontologies dealing with the interactions
of a protein with other biomolecules. Currently,
most approaches to building such ontologies focus
on metabolism [3,6]. So far, for interactions, only
high-level classiﬁcations have been created [4],
developed to assist information extraction from
text. In addition to assisting text mining, a more
ﬁne-grained (in comparison to these classiﬁcations)
ontology on protein interactions could be help-
ful in database development and information min-
ing. As an ontology captures domain knowledge
in a computer-understandable way, it can be used
for inferencing, i.e. deriving new knowledge from
existing data.
There are two important points to consider in
developing such a formal ontology: (a) it should
be independent of its ﬁnal use; and (b) it should
not only restrict itself to a controlled vocabulary
but the concepts should be related to each other
in a semantically consistent manner, and rules
governing these deﬁnitions and relations should be
incorporated whenever necessary. Here we describe
our approach for developing such an ontology.
Development of the ontology
Our general procedure when developing an ontol-
ogy involves ﬁve steps:
1. The identiﬁcation of its scope.
2. The identiﬁcation of the concepts needed and
the properties thereof.
3. The decision on how these entities and relation-
ships are to be represented.
4. The deﬁnition of rules and constraints.
5. The formalization.
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Scope
The ontology we are developing is intended to
represent interactions between proteins and other
cellular compounds, including proteins, nucleic
acids, lipids and ions. We have restricted the
description of these interactions to a molecular
level, i.e. to the level of interactions with amino
acids. Although it would be feasible to describe
the interactions at an atomic level, based on three-
dimensional structures, most of the concepts can be
sufﬁciently described at the higher level of amino
acids, and most of the interaction data available is
at that level.
In the initial phase, we focus on interactions
associated with signal transduction, for two rea-
sons. First, these processes rely strongly on protein
interactions. Second, they are important regulatory
processes, frequently involved in the development
of diseases. We decided to concentrate on the repre-
sentation of qualitative aspects of these pathways.
No quantitative properties, such as the concentra-
tion of compounds involved, are modelled, given
that, in contrast to metabolic pathways, the concen-
tration of compounds involved in signal transduc-
tion pathways is often not measurable.
A signal transduction pathway contains at least
parts of a path that, in most cases, transfers a sig-
nal from the outside of the cell into its nucleus.
This signal transfer is performed by a chain of
interacting proteins, as we will exemplify with the
Jak–Stat pathway (Figure 1; for a review see [1]).
It starts at the cellular membrane, where a ligand
binds to a receptor, leading to the oligomeriza-
tion of the receptor. The Jak proteins bound to the
intracellular part of the receptor are activated upon
oligomerization of the receptor. They phosphory-
late both the receptor and Stat proteins, which bind
to the phosphorylated receptor. Once phosphory-
lated, Stat proteins can dimerize, which enables
them to enter the nucleus and upregulate the tran-
scription of a set of target genes.
Such signal transduction cascades enable the cell
to respond to environmental changes. Since several
signal transduction pathways are interrelated and
form a regulatory network, fast and appropriate
answers to such changes are possible.
Concepts involved
When looking at a typical signal transduction path-
way we can identify two main concepts needed for
the representation of protein interactions: the inter-
acting compounds and the interactions themselves.
The interacting compounds are proteins, nucleic
acids and other compounds, such as ions, and can
be composed of sub-parts. Proteins, for example,
are composed of amino acids and contain regions
with deﬁned functions, known as domains. Apart
from the actual characteristics of a protein, such as
its sequence, the molecular weight and the isoelec-
tric point, there are at least three different factors
Figure 1. Schematic model of the Jak–Stat pathway (see text)
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that deﬁne the interaction potential of a protein: its
modiﬁcations, its location and its binding partners.
The protein interactions are what really make
up a signal transduction pathway. There are dif-
ferent types of interactions, e.g. binding, phospho-
rylation, cleavage or translocation. Although from
a conceptual point of view translocation, phos-
phorylation and cleavage do not constitute actual
interactions, but are really the consequence of an
interaction, in the biological domain these con-
cepts are grouped under the heading of interactions,
probably because they are integral parts of many
signal transduction pathways and involve interac-
tion with proteins. Thus, we have decided to refer
to them also as interactions. An additional classi-
ﬁcation has been made based on functional sim-
ilarity, grouping more than 100 verbs extracted
from SWISS-PROT function descriptions into 11
not-disjoint, i.e. partially overlapping, classes: Con-
trol/Regulation; Biochemical Interactions; Logical
Interactions; Bind/Dissociate; Formation; Integrity;
Availability; Change of Location; Modiﬁcation of
Structure; Special Processes/Reactions; and Order.
We are now working on the consolidation, exten-
sion and hierarchical arrangement of these classiﬁ-
cations.
Representation of the identiﬁed concepts
The interaction potential of a protein is deﬁned
in terms of its state. A protein state is made
up of a localization, a list of modiﬁcations and
a list of binding partners, e.g. a protein can be
phosphorylated at one amino acid residue, be
located in the cytoplasm and be bound to no other
proteins. This is a similar approach to that of the
LiveDIP [2].
An interaction can be represented as an event
with a pre- and a post-condition. The pre-condition
is deﬁned in terms of the characteristics of the
states that the participating proteins have to ful-
ﬁl in order for the interaction to take place.
The post-condition describes the resulting states
of these proteins. Therefore, an interaction event
is described by the pre-states and post-states of
the involved proteins, e.g. a translocation event
changes the value of the localization but leaves the
other attributes unchanged, whereas a phosphory-
lation event changes only the modiﬁcations value.
Rules, constraints and their formalization
The rules describing protein interactions in a
computer-understandable way and the constraints
included to guarantee the consistency of data are
what distinguish a formal ontology from a con-
trolled vocabulary. These rules and constraints rep-
resent the knowledge of ﬁeld experts used when
validating data, sometimes without even noticing.
Even if these rules and their scientiﬁc signiﬁcance
are known to the biologists, most of them are not
formalized, which is necessary for validation pro-
cesses to be carried out by computers. An example
of such a rule is the fact that a eukaryotic pro-
tein can only be phosphorylated at certain amino
acids, which are tyrosine (Y, phosphorylated by a
Y-kinase), or threonine (T) or serine (S) (phospho-
rylated by an S/T-kinase). These two kinases are
protein kinases, which are types of proteins. This
can be formalized in ﬁrst-order logic in the follow-
ing way:
∀X : [protein-kinase(X) → protein(X)]
∀X : [Y-kinase(X) → protein-kinase(X)]
∀X:[ S /T-kinase(X) → protein-kinase(X)]
∀X:[ S /T-kinase(X) →¬ Y-kinase(X)]
∀X : [Y-kinase(X) →¬ S/T-kinase(X)]
We decided to use ﬁrst-order logic for the for-
malization to keep the ontology development inde-
pendent of its implementation, which can be done
using different tools and for different applications.
If there is anything that comes close to a lingua
franca in logic, computer science and their appli-
cations, it is first-order predicate logic (FOL). FOL
has well-understood semantics and inference meth-
ods. Furthermore, there are correspondence theo-
ries that allow one to express temporal and modal
dependencies within FOL. Hence, the expressive
power of FOL was sufﬁcient for our purposes. This
does not mean that we want, or need to, exploit all
the capacities of FOL in modelling our domain,
but it is convenient to have such a powerful lan-
guage to make the domain knowledge explicit and
precise. For real applications we then can translate
our axioms into systems with less expressive power
(e.g. description logics) but that guarantee certain
computational properties (e.g. decidability).
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To represent interactions, let us take as an exam-
ple a phosphorylation, represented, like all interac-
tions, as an event. This implies that we have to
specify the pre- and post-conditions. Before the
phosphorylation takes place the speciﬁc part R
(residue) of the protein P [is residue of(R,P) and
protein(P)], which is to be phosphorylated, has to
be unmodiﬁed [¬modiﬁed(R)]. After the phospho-
rylation takes place, the speciﬁc residue will be
phosphorylated [phosphorylated(R)]. A residue is
modiﬁed if it has been phosphorylated, glycosy-
lated, etc., formally:
∀R,s[s : modiﬁed(R) ↔ (phosphorylated(R)
∨ glycosylated(R) ∨ ...)]
Assuming that the predicates protein(X), protein-
kinase(X), is residue of(X,Y) phosphorylated(X) and
result(X) have already been deﬁned in the ontology,
a phosphorylation can be formalized as:
∀e,s,s ,P,Q,R[e : phosphorylation(P,Q,R)
↔ (protein(P) ∧ protein-kinase(Q)
∧ is residue of(R,P) ∧ s:¬modiﬁed(R) ∧ s  :
phosphorylated(R) ∧ result(e) = s  ∧ s ⊃⊂ e)]
Here, the temporal order of the states and events
is imposed by the use of two relations. The
function result, applied to an event e, returns the
resulting state s  of the event. This implies a
temporal succession of e by s , such that s  comes
immediately after e. In addition, the abut-relation
s ⊃⊂ e indicates that s is immediately followed
by e.
Given this formalization of a phosphorylation
event and the above hierarchy of protein-kinases,
we can now express that the phosphorylated residue
and the type of kinase are mutually dependent:
∀e,P,Q,R[e : phosphorylation(P,Q,R) ∧ S/T
-kinase(Q) → (threonine(R) ∨ serine(R))]
∀e,P,Q,R[e : phosphorylation(P,Q,R)
∧ (threonine(R) ∨ serine(R)) → S/T-kinase(Q)]
Such rules have to be included in the ontology to
prevent phosphorylation events on any other amino
acid. In addition, the phosphorylation event is a
kind of interaction, which gives us the possibility
to infer the co-location of the interacting partners:
∀e,P,Q,R[e : phosphorylation(P,Q,R)
→ e : interaction(P,Q)]
∀e,P,Q[e : interaction(P,Q) → loc(Q)
= x ∧ loc(P) = y ∧ at(x,y)]
This formula assumes a ﬁne-grain ontology of loca-
tions, although we are aware that most localization
data available are limited to the level of com-
partments in which compounds are located. The
inference that the interacting elements have to be
co-located is limited to being close to each other
[at(x,y)] and thus in the same compartment.
Challenges met
In our approach to develop an ontology for protein
interactions, we had to face different challenges,
which mainly emerged from the need for abstrac-
tion, the actual implementation of the ontology,
the domain being analysed and the interdisciplinar-
ity of the group. This last factor turned out to
be both a challenge and a beneﬁt to our work.
The group working on this ontology is composed
of computer scientists, computational linguists and
biologists. These different backgrounds force all
group members to formulate their concepts in a
precise and understandable way. As a result, ambi-
guities become clear and can be approached at a
very early stage in ontology development. Further-
more, every discipline plans to use the ontology for
different projects, leading to the development of a
project independent ontology.
Challenges typical for the biological domain
arise because of the granularity of information.
Realistically, an interaction between two proteins
takes place between deﬁned atoms of distinct
amino acids of these proteins. However, this level
of detail is usually not known. For well-understood
and experimentally characterized interactions, the
interacting amino acids might be known, but
in most cases only the interacting domains are
described. In the case of data derived from large-
scale proteomics analyses, only the names of the
interacting proteins are given. Frequently, these dif-
ferent levels of detail are mixed, as in cases where
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one partner is only known as the protein name, but
for the other partner the amino acids involved are
also given. In addition to this three-layered gran-
ularity of information, another granularity exists.
Signal transduction pathways can be described on a
general (organism-independent) level, talking about
protein families, e.g. in the way the Jak–Stat path-
way has been described above. However, there are
several members of the Jak- and Stat-protein fam-
ilies, respectively, so these pathways can also be
described at the level of orthologous groups, e.g.
where a Jak2 protein interacts with a Stat5 protein.
Finally, one could be interested in the actual pro-
teins within a speciﬁc organism, e.g. distinguish-
ing mouse-Jak1 from rat-Jak1. These two types of
granularities have to be combined to allow the rep-
resentation of partial information.
Future developments
We are currently improving the representation of
the underlying concepts and increasing the cover-
age of the ontology. Although it is still in a very
early state, we have started to use the knowledge
generated in developing the interactions ontology
in related projects. To mine relations between pro-
tein interactions and metabolic pathways, the ontol-
ogy is being integrated into an already existent
ontology developed at the EML [5], which focuses
on metabolic pathways.
Based on parts of the protein interactions
ontology, we automatically translate the content
of SWISS-PROT feature table lines into fully
structured tree-like representations that can be
queried and graphically displayed by using the
TIGERSearch engine (developed at the University
of Stuttgart; Lezius, PhD thesis to be submitted).
The TIGERSearch software is a specialized search
engine for querying datasets of tree-like structures,
so-called ‘treebanks’.
In view of the increasing number and coverage of
databases concerned with signalling pathways, such
as CSNDB [7], we envision using the ontology
to annotate these pathways. This could lead to an
increased insight into the molecular details of the
interactions within cellular networks.
This deﬁnition of sub-projects, where the ontol-
ogy plays a key role, helps us on the one hand to
evaluate its applicability, and on the other hand jus-
tiﬁes the amount of effort that goes into the process
of developing an ontology. Based on our experi-
ences, the creation of interdisciplinary groups for
ontology development turned out to be very ben-
eﬁcial. The combination of these two factors, i.e.
the multiple applications and the interdisciplinary
nature of the group, is an approach we highly
recommend to other groups wanting to create an
ontology for a speciﬁc domain.
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